INS and diabetes mellitus: Growth of the relative area of insulin-positive endocrine cells and Langerhans pancreatic islet perimeter observed in animals with experimental diabetes mellitus receiving ZB-16 at a dose of 1 mg/kg support the hypothesis that it acts as a protective agent for β-cells.